MoneyWorks4Me

Boston Bio Systems informs about outcome of board meeting

14 Nov 2024 Evaluate
Boston Bio Systems has informed that Board of directors of the company at its meeting held on Thursday, November 14, 2024, has considered and approved Standalone un-audited financial results of the company for the quarter and half year ended September 30, 2024. A copy of said results along with the Limited Review report of the Statutory Auditors is attached as ‘Annexure A’,

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Lenskart Solutions 686.15
Poly Medicure 1630.00
Molbio Diagnostics 1497.00
Laxmi Dental 192.30
GKB Ophthalmics 64.00
View more..